In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its ...
A Japanese health ministry panel has endorsed two products using iPS cells, paving the way for the world's first practical ...
Japanese government experts endorsed on Thursday ground-breaking projects to manufacture regenerative medicine products to ...
bit.bio's ioSensory Neurons pain research was selected for presentation at SfN’s Neuroscience 2024 press conference, and it was chosen from over 10,500+ submissions. bit.bio will host an expert panel ...
Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response ...
The iPSC-derived NK cells clinical trial analysis report delivers important insights into ongoing research of 15+ pipeline iPSC-derived NK cells drugs, clinical strategies, upcoming therapeutics, and ...
Tokyo-based K Pharma Inc. and Nikon Cell Innovation Co. on Tuesday signed a basic agreement on a new clinical trial project using induced pluripotent stem (iPS) cells to treat spinal cord injuries.
PALO ALTO, Calif., Jan. 30, 2026 /PRNewswire/ -- Leading GMP cell therapy CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent stem cells ...
Century Therapeutics, Inc. (IPSC) is a very interesting cell therapy biotech, especially with the accomplishments it has been able to make thus far. That's because it released positive interim data as ...
The fact that the researchers replaced retroviruses with adenoviruses is an important step, added Brivanlou, but adenoviruses still can integrate into the genome, albeit rarely. In order for iPS cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results